Combination Products
1 - 15 of
25 Results
Sort Results:
Article:
Nesina (nes-SEE-na, alogliptin) will compete for your prescription in a crowded market of gliptins for type 2 diabetes
August 2013
Article:
You'll hear claims that gliptins (Januvia, etc) decrease cardiovascular risk in diabetes patients
November 2011
Article:
The ADA is dropping its recommendation for Avandia and now recommends a back-to-basics approach for treating type 2 diabetes
December 2008
Guideline:
2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes
December 2008